Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213
Abstract
Intracranial arterial stenosis is a major cause of ischemic stroke worldwide, particularly in the Asian population. Although traditionally regarded as a manifestation of atherosclerotic disease, increasing evidence suggests that non-atherosclerotic arteriopathies also contribute substantially to its pathogenesis. These conditions, including arterial dissection, inflammatory vasculopathies, and moyamoya disease, often share overlapping clinical and imaging features, thus making precise differentiation challenging in routine practice.This phenotypic overlap highlights the heterogeneity of intracranial arterial stenosis and suggests that it may represent a spectrum of vascular disorders, rather than a single disease entity. Recent studies have highlighted the role of genetic susceptibility as a factor underlying this diversity. Among these, RNF213, originally identified as a susceptibility gene for moyamoya disease, has been implicated in a subset of intracranial arterial diseases beyond the classical diagnostic categories. These observations have led to the concept of RNF213-related vasculopathy, which extends beyond intracranial circulation and provides a framework for understanding diverse vascular phenotypes within a broader context. In addition, a two-hit model has been proposed in which genetic susceptibility interacts with environmental and acquired factors to influence the disease onset and progression.This narrative review summarizes the current understanding of intracranial arterial stenosis beyond the conventional atherosclerosis-centered paradigm and discusses emerging concepts integrating vascular heterogeneity, genetic susceptibility, and environmental modifiers with potential implications for disease classification and individualized therapeutic strategies.
Related
- Associations of the triglyceride-glucose index and intracranial arterial stenosis with poor functional outcome after ischemic stroke: a retrospective observational study of 712 patients
- Diagnostic and prognostic value of on-site CT-derived fractional flow reserve in intracranial atherosclerotic stenosis
- The clinical application of a low-profile stent for symptomatic intracranial atherosclerotic stenosis in the middle cerebral artery: a retrospective study of the Atlas stent
- Multifocal intracranial aneurysms and a clinical diagnosis of ruptured retinal arterial macroaneurysm in presumed hepatitis B-associated polyarteritis nodosa: A case report
- Hemodynamic biomarkers in symptomatic intracranial atherosclerotic stenosis: evidence boundaries and research pathways from prognostic stratification to treatment-effect prediction
BibTeX
@article{okazaki2026intracranial,
title = {{Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213}},
author = {Shuhei Okazaki},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
month = sep,
doi = {10.5551/jat.rv22053},
url = {https://www.jstage.jst.go.jp/article/jat/33/9/33_RV22053/_article},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213
AU - Shuhei Okazaki
PY - 2026
DA - 2026/09/01
JO - Journal of Atherosclerosis and Thrombosis
DO - 10.5551/jat.rv22053
UR - https://www.jstage.jst.go.jp/article/jat/33/9/33_RV22053/_article
AB - Intracranial arterial stenosis is a major cause of ischemic stroke worldwide, particularly in the Asian population. Although traditionally regarded as a manifestation of atherosclerotic disease, increasing evidence suggests that non-atherosclerotic arteriopathies also contribute substantially to its pathogenesis. These conditions, including arterial dissection, inflammatory vasculopathies, and moyamoya disease, often share overlapping clinical and imaging features, thus making precise differentiation challenging in routine practice.This phenotypic overlap highlights the heterogeneity of intracranial arterial stenosis and suggests that it may represent a spectrum of vascular disorders, rather than a single disease entity. Recent studies have highlighted the role of genetic susceptibility as a factor underlying this diversity. Among these, RNF213, originally identified as a susceptibility gene for moyamoya disease, has been implicated in a subset of intracranial arterial diseases beyond the classical diagnostic categories. These observations have led to the concept of RNF213-related vasculopathy, which extends beyond intracranial circulation and provides a framework for understanding diverse vascular phenotypes within a broader context. In addition, a two-hit model has been proposed in which genetic susceptibility interacts with environmental and acquired factors to influence the disease onset and progression.This narrative review summarizes the current understanding of intracranial arterial stenosis beyond the conventional atherosclerosis-centered paradigm and discusses emerging concepts integrating vascular heterogeneity, genetic susceptibility, and environmental modifiers with potential implications for disease classification and individualized therapeutic strategies.
SN - 1880-3873
SN - 1340-3478
ER -